Cell Surface Markers Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Cell surface markers are distinct molecules that are present on cell surfaces. Cell surface markers are used to identify and classify different cells. These markers play a vital role in immunology. Hematology analysis involves diagnosis and identification of such markers in order to make a diagnosis. Instruments such as flow cytometers, and hematology analyzers are used for this purpose.

Restraints of the Global Cell Surface Markers Market

Major factors hampering the growth of the cell surface markers market during the forecast period constitutes of reluctance of laboratories, and pharmaceutical industry to investment in costly sophisticated diagnostic models.

Key features of the study:

• This report provides in-depth analysis of the global cell surface markers market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global cell surface markers market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific, Inc.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cell surface markers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Cell Surface Markers Market, By Product Type:

• Flow Cytometers
• Hematology Analyzers
• Reagents and Kits

Global Cell Surface Markers Market, By Application:

• Disease Diagnosis and identification
• Research/Drug Discovery

Global Cell Surface Markers Market, By Geography:

• North America

o By Country:

• U.S.
• Canada
• Europe

o By Country:

• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific

o By Country:

• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America

o By Country:

• Brazil
• Mexico
• Argentina
• Rest of Latin America

o Middle East:

o By Country:

• GCC
• Israel
• Rest of Middle East
• Africa

o By Country/Region:

• Central Africa
• South Africa
• North Africa
• Company Profiles
• Abbott Laboratories, Inc.*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
• Beckman Coulter, Inc.
• BD Biosciences
• Bio-Rad Laboratories, Inc.
• Grifols SA
• Immucor, Inc.
• Janssen Diagnostics, Inc.
• Nihon Kohden Corporation
• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.

“*” marked represents similar segmentation in other categories in the respective section.